FOXO TECHNOLOGIES INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that FOXO TECHNOLOGIES INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $16.37M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $4.05M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $145.3K | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $511.0K | Jun 6, 2024 |
| FY2022 | Dec 31, 2021 | $120.0K | Mar 31, 2023 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $16.37M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $4.05M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $145.3K | Apr 15, 2025 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $13.0K | Jun 6, 2024 |
| FY2023 | Dec 31, 2022 | $167.0K | Jun 6, 2024 |
| FY2022 | Dec 31, 2021 | $120.0K | Mar 31, 2023 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($12.43M) | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | ($12.41M) | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | ($26.45M) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | ($95.26M) | Jun 6, 2024 |
| FY2022 | Dec 31, 2021 | ($38.49M) | Mar 31, 2023 |
| FY2020 | Dec 31, 2020 | ($1.78M) | May 17, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($10.33M) | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | ($7.76M) | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | ($22.19M) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | ($40.17M) | Jun 6, 2024 |
| FY2021 | Dec 31, 2021 | ($1.30M) | Mar 7, 2022 |
| FY2021 | Dec 31, 2020 | ($1.15M) | Mar 7, 2022 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $182.5K | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $312.3K | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $900.4K | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $3.05M | Jun 6, 2024 |
| FY2022 | Dec 31, 2021 | $4.88M | Mar 31, 2023 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.36M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $7.23M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $19.40M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $25.83M | Jun 6, 2024 |
| FY2022 | Dec 31, 2021 | $10.27M | Mar 31, 2023 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($3.87M) | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | ($2.84M) | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | ($6.65M) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | ($23.76M) | Jun 6, 2024 |
| FY2022 | Dec 31, 2021 | ($15.06M) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($481.4K) | Mar 7, 2022 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $62.0K | Apr 15, 2026 |
| FY2023 | Dec 31, 2022 | $110.0K | Jun 6, 2024 |
| FY2022 | Dec 31, 2021 | $118.0K | Mar 31, 2023 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $44.58M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $41.71M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $725.7K | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $35.41M | Jun 6, 2024 |
| FY2022 | Dec 31, 2021 | $30.30M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $203.14M | Mar 7, 2022 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $33.50M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $36.44M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $14.83M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $28.70M | Jun 6, 2024 |
| FY2022 | Dec 31, 2021 | $55.52M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $18.08M | Mar 7, 2022 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.14M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $5.32M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | ($14.10M) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $6.71M | Jun 6, 2024 |
| FY2023 | Dec 31, 2021 | ($25.22M) | Jun 6, 2024 |
| FY2022 | Dec 31, 2020 | $8.72M | Mar 31, 2023 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $27.82M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $25.46M | Apr 15, 2026 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($224.64M) | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | ($190.54M) | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | ($177.06M) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | ($147.23M) | Jun 6, 2024 |
| FY2022 | Dec 31, 2021 | ($51.98M) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($16.19M) | Mar 7, 2022 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $207.5K | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $68.3K | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $38.1K | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $5.52M | Jun 6, 2024 |
| FY2022 | Dec 31, 2021 | $6.86M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $1.42M | Mar 7, 2022 |